Salt substitute clinical trials
How each study uses salt substitute is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the salt substitute studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Salt Substitute
- 4
Studies by the year they started
4 studies that test it; most in 2009 (1); 1 more planned to start later
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2014 | 1 |
| 2022 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 5
The George Institute for Global Health, China (1) · NYU Langone Health (1) · Jinling Hospital, China (1) · Estudios Clínicos Latino América (1) · Beijing Jishuitan Hospital (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test salt substitute.
- Jun 2027Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney DiseaseNot applicable · NYU Langone Health
Studies
Open first, then newest update. How each study uses salt substitute is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney DiseaseNot yet recruitingNot applicableNYU Langone HealthNCT05558267Written as Salt SubstituteHow we know
- Kidney-protective Intervention With Salt Substitute After Kidney Tumor SurgeryTerminatedNot applicableJinling Hospital, ChinaNCT07062952Written as Salt substituteHow we know
- The ECLA/PHRI Intervention in the Community TrialStatus unknownNot applicableEstudios Clínicos Latino AméricaNCT05638009Written as Salt substitute 66%33%How we know
- China Salt Substitute Study in TibetCompletedNot applicableThe George Institute for Global Health, ChinaNCT01429246Written as Salt SubstituteHow we know
- Tibet Salt Reduction StudyStatus unknownNot applicableBeijing Jishuitan HospitalNCT02021435Written as salt substituteHow we know
What changed recently
From the registry's own updates since Oct 23, 2026.
Stopped1
- Kidney-protective Intervention With Salt Substitute After Kidney Tumor SurgeryTerminatedNov 9, 2026NCT07062952
Codes
What other systems call salt substitute · ClinicalTrials.gg INT016778
- UNII (FDA) HJT620308CSALT SUBSTITUTEOne source FDA
- NCI Thesaurus C71943Salt SubstituteOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | HJT620308C | SALT SUBSTITUTE | One source FDA |
| NCI Thesaurus | C71943 | Salt Substitute | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.